位置:首页 > 蛋白库 > LINB_SPHJU
LINB_SPHJU
ID   LINB_SPHJU              Reviewed;         296 AA.
AC   D4Z2G1; P51698;
DT   18-JUL-2018, integrated into UniProtKB/Swiss-Prot.
DT   15-JUN-2010, sequence version 1.
DT   03-AUG-2022, entry version 75.
DE   RecName: Full=Haloalkane dehalogenase {ECO:0000255|HAMAP-Rule:MF_01231, ECO:0000303|PubMed:9293022};
DE            EC=3.8.1.5 {ECO:0000255|HAMAP-Rule:MF_01231, ECO:0000269|PubMed:9293022};
DE   AltName: Full=1,3,4,6-tetrachloro-1,4-cyclohexadiene halidohydrolase {ECO:0000303|PubMed:9293022};
DE            Short=1,4-TCDN halidohydrolase {ECO:0000303|PubMed:9293022};
GN   Name=linB {ECO:0000303|PubMed:7691794, ECO:0000303|PubMed:9293022};
GN   OrderedLocusNames=SJA_C1-19590 {ECO:0000312|EMBL:BAI96793.1};
OS   Sphingobium japonicum (strain DSM 16413 / CCM 7287 / MTCC 6362 / UT26 /
OS   NBRC 101211 / UT26S).
OC   Bacteria; Proteobacteria; Alphaproteobacteria; Sphingomonadales;
OC   Sphingomonadaceae; Sphingobium.
OX   NCBI_TaxID=452662;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], PROTEIN SEQUENCE OF 2-16, FUNCTION,
RP   CATALYTIC ACTIVITY, AND PATHWAY.
RC   STRAIN=DSM 16413 / CCM 7287 / MTCC 6362 / UT26 / NBRC 101211 / UT26S;
RX   PubMed=7691794; DOI=10.1128/jb.175.20.6403-6410.1993;
RA   Nagata Y., Nariya T., Ohtomo R., Fukuda M., Yano K., Takagi M.;
RT   "Cloning and sequencing of a dehalogenase gene encoding an enzyme with
RT   hydrolase activity involved in the degradation of gamma-
RT   hexachlorocyclohexane in Pseudomonas paucimobilis.";
RL   J. Bacteriol. 175:6403-6410(1993).
RN   [2]
RP   SEQUENCE REVISION.
RA   Nagata Y., Nariya T., Ohtomo R., Fukuda M., Yano K., Takagi M.;
RL   Submitted (MAR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=DSM 16413 / CCM 7287 / MTCC 6362 / UT26 / NBRC 101211 / UT26S;
RX   PubMed=20817768; DOI=10.1128/jb.00961-10;
RA   Nagata Y., Ohtsubo Y., Endo R., Ichikawa N., Ankai A., Oguchi A., Fukui S.,
RA   Fujita N., Tsuda M.;
RT   "Complete genome sequence of the representative gamma-
RT   hexachlorocyclohexane-degrading bacterium Sphingobium japonicum UT26.";
RL   J. Bacteriol. 192:5852-5853(2010).
RN   [4]
RP   PROTEIN SEQUENCE OF 2-10, AND SUBCELLULAR LOCATION.
RC   STRAIN=DSM 16413 / CCM 7287 / MTCC 6362 / UT26 / NBRC 101211 / UT26S;
RX   PubMed=10464214; DOI=10.1128/jb.181.17.5409-5413.1999;
RA   Nagata Y., Futamura A., Miyauchi K., Takagi M.;
RT   "Two different types of dehalogenases, LinA and LinB, involved in gamma-
RT   hexachlorocyclohexane degradation in Sphingomonas paucimobilis UT26 are
RT   localized in the periplasmic space without molecular processing.";
RL   J. Bacteriol. 181:5409-5413(1999).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, SUBSTRATE
RP   SPECIFICITY, AND SUBUNIT.
RC   STRAIN=DSM 16413 / CCM 7287 / MTCC 6362 / UT26 / NBRC 101211 / UT26S;
RX   PubMed=9293022; DOI=10.1128/aem.63.9.3707-3710.1997;
RA   Nagata Y., Miyauchi K., Damborsky J., Manova K., Ansorgova A., Takagi M.;
RT   "Purification and characterization of a haloalkane dehalogenase of a new
RT   substrate class from a gamma-hexachlorocyclohexane-degrading bacterium,
RT   Sphingomonas paucimobilis UT26.";
RL   Appl. Environ. Microbiol. 63:3707-3710(1997).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, MUTAGENESIS OF
RP   ASP-108; GLU-132; GLU-244 AND HIS-272, AND ACTIVE SITE.
RC   STRAIN=DSM 16413 / CCM 7287 / MTCC 6362 / UT26 / NBRC 101211 / UT26S;
RX   PubMed=10100638; DOI=10.1016/s0014-5793(99)00199-4;
RA   Hynkova K., Nagata Y., Takagi M., Damborsky J.;
RT   "Identification of the catalytic triad in the haloalkane dehalogenase from
RT   Sphingomonas paucimobilis UT26.";
RL   FEBS Lett. 446:177-181(1999).
RN   [7]
RP   QUANTUM MECHANIC STUDIES, AND MUTAGENESIS OF ASN-38; TRP-109; PHE-151 AND
RP   PHE-169.
RX   PubMed=12450392; DOI=10.1021/bi026427v;
RA   Bohac M., Nagata Y., Prokop Z., Prokop M., Monincova M., Tsuda M., Koca J.,
RA   Damborsky J.;
RT   "Halide-stabilizing residues of haloalkane dehalogenases studied by quantum
RT   mechanic calculations and site-directed mutagenesis.";
RL   Biochemistry 41:14272-14280(2002).
RN   [8]
RP   CRYSTALLIZATION.
RC   STRAIN=DSM 16413 / CCM 7287 / MTCC 6362 / UT26 / NBRC 101211 / UT26S;
RX   PubMed=10329794; DOI=10.1107/s090744499900459x;
RA   Smatanova I.K., Nagata Y., Svensson L.A., Takagi M., Marek J.;
RT   "Crystallization and preliminary X-ray diffraction analysis of haloalkane
RT   dehalogenase LinB from Sphingomonas paucimobilis UT26.";
RL   Acta Crystallogr. D 55:1231-1233(1999).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.58 ANGSTROMS) OF NATIVE PROTEIN AND COMPLEX WITH
RP   1,3-PROPANEDIOL.
RC   STRAIN=DSM 16413 / CCM 7287 / MTCC 6362 / UT26 / NBRC 101211 / UT26S;
RX   PubMed=11087355; DOI=10.1021/bi001539c;
RA   Marek J., Vevodova J., Smatanova I.K., Nagata Y., Svensson L.A., Newman J.,
RA   Takagi M., Damborsky J.;
RT   "Crystal structure of the haloalkane dehalogenase from Sphingomonas
RT   paucimobilis UT26.";
RL   Biochemistry 39:14082-14086(2000).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF COMPLEXES WITH 1,2-DICHLOROETHANE;
RP   1,2-DICHLOROPROPANE AND BUTAN-1-OL.
RC   STRAIN=DSM 16413 / CCM 7287 / MTCC 6362 / UT26 / NBRC 101211 / UT26S;
RX   PubMed=11939779; DOI=10.1021/bi015734i;
RA   Oakley A.J., Prokop Z., Bohac M., Kmunicek J., Jedlicka T., Monincova M.,
RA   Kuta-Smatanova I., Nagata Y., Damborsky J., Wilce M.C.J.;
RT   "Exploring the structure and activity of haloalkane dehalogenase from
RT   Sphingomonas paucimobilis UT26: evidence for product- and water-mediated
RT   inhibition.";
RL   Biochemistry 41:4847-4855(2002).
RN   [11] {ECO:0007744|PDB:1IZ7, ECO:0007744|PDB:1IZ8, ECO:0007744|PDB:1K5P, ECO:0007744|PDB:1K63, ECO:0007744|PDB:1K6E}
RP   X-RAY CRYSTALLOGRAPHY (1.58 ANGSTROMS) OF NATIVE PROTEIN AND COMPLEXES WITH
RP   1,2-PROPANEDIOL; 1-BROMOPROPAN-2-OL AND 2-BROMO-2-PROPEN-1-OL, AND ACTIVE
RP   SITE.
RC   STRAIN=DSM 16413 / CCM 7287 / MTCC 6362 / UT26 / NBRC 101211 / UT26S;
RX   PubMed=12939138; DOI=10.1021/bi027280a;
RA   Streltsov V.A., Prokop Z., Damborsky J., Nagata Y., Oakley A., Wilce M.C.;
RT   "Haloalkane dehalogenase LinB from Sphingomonas paucimobilis UT26: X-ray
RT   crystallographic studies of dehalogenation of brominated substrates.";
RL   Biochemistry 42:10104-10112(2003).
RN   [12] {ECO:0007744|PDB:1MJ5}
RP   X-RAY CRYSTALLOGRAPHY (0.95 ANGSTROMS) IN COMPLEX WITH CHLORIDE, AND ACTIVE
RP   SITE.
RC   STRAIN=DSM 16413 / CCM 7287 / MTCC 6362 / UT26 / NBRC 101211 / UT26S;
RX   PubMed=14744129; DOI=10.1021/bi034748g;
RA   Oakley A.J., Klvana M., Otyepka M., Nagata Y., Wilce M.C., Damborsky J.;
RT   "Crystal structure of haloalkane dehalogenase LinB from Sphingomonas
RT   paucimobilis UT26 at 0.95 A resolution: dynamics of catalytic residues.";
RL   Biochemistry 43:870-878(2004).
RN   [13] {ECO:0007744|PDB:2BFN}
RP   X-RAY CRYSTALLOGRAPHY (1.60 ANGSTROMS) IN COMPLEX WITH
RP   2,3-DICHLOROPROPAN-1-OL AND CHLORIDE.
RX   PubMed=17259360; DOI=10.1128/aem.02416-06;
RA   Monincova M., Prokop Z., Vevodova J., Nagata Y., Damborsky J.;
RT   "Weak activity of haloalkane dehalogenase LinB with 1,2,3-trichloropropane
RT   revealed by X-Ray crystallography and microcalorimetry.";
RL   Appl. Environ. Microbiol. 73:2005-2008(2007).
RN   [14] {ECO:0007744|PDB:4WDQ, ECO:0007744|PDB:4WDR, ECO:0007744|PDB:5LKA}
RP   X-RAY CRYSTALLOGRAPHY (1.30 ANGSTROMS) OF WILD-TYPE AND MUTANTS TRP-177 AND
RP   ALA-140/LEU-143/TRP-177/LEU-211, AND MUTAGENESIS STUDIES.
RX   DOI=10.1021/acscatal.6b02081;
RA   Brezovsky J., Babkova P., Degtjarik O., Fortova A., Gora A., Iermak I.,
RA   Rezacova P., Dvorak P., Kuta Smatanova I., Prokop Z., Chaloupkova R.,
RA   Damborsky J.;
RT   "Engineering a de novo transport tunnel.";
RL   ACS Catal. 6:7597-7610(2016).
CC   -!- FUNCTION: Catalyzes hydrolytic cleavage of carbon-halogen bonds in
CC       halogenated aliphatic compounds, leading to the formation of the
CC       corresponding primary alcohols, halide ions and protons. Has a broad
CC       substrate specificity since not only monochloroalkanes (C3 to C10) but
CC       also dichloroalkanes (> C3), bromoalkanes, and chlorinated aliphatic
CC       alcohols are good substrates (PubMed:9293022, PubMed:10100638). Shows
CC       almost no activity with 1,2-dichloroethane, but very high activity with
CC       the brominated analog (PubMed:9293022). Is involved in the degradation
CC       of the important environmental pollutant gamma-hexachlorocyclohexane
CC       (gamma-HCH or lindane) as it also catalyzes conversion of 1,3,4,6-
CC       tetrachloro-1,4-cyclohexadiene (1,4-TCDN) to 2,5-dichloro-2,5-
CC       cyclohexadiene-1,4-diol (2,5-DDOL) via the intermediate 2,4,5-
CC       trichloro-2,5-cyclohexadiene-1-ol (2,4,5-DNOL) (PubMed:7691794). This
CC       degradation pathway allows S.japonicum UT26 to grow on gamma-HCH as the
CC       sole source of carbon and energy. {ECO:0000269|PubMed:10100638,
CC       ECO:0000269|PubMed:7691794, ECO:0000269|PubMed:9293022}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-haloalkane + H2O = a halide anion + a primary alcohol +
CC         H(+); Xref=Rhea:RHEA:19081, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:15734, ChEBI:CHEBI:16042, ChEBI:CHEBI:18060; EC=3.8.1.5;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_01231,
CC         ECO:0000269|PubMed:10100638, ECO:0000269|PubMed:9293022};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(3R,6R)-1,3,4,6-tetrachlorocyclohexa-1,4-diene + 2 H2O = 2,5-
CC         dichlorocyclohexa-2,5-dien-1,4-diol + 2 chloride + 2 H(+);
CC         Xref=Rhea:RHEA:11944, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17996, ChEBI:CHEBI:18904, ChEBI:CHEBI:28975;
CC         Evidence={ECO:0000269|PubMed:7691794};
CC   -!- ACTIVITY REGULATION: Competitively inhibited by the key pollutants 1,2-
CC       dichloroethane (1,2-DCE) and 1,2-dichloropropane (1,2-DCP).
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.9 mM for 1,2-dibromoethane {ECO:0000269|PubMed:9293022};
CC         KM=3.9 mM for 1-chloro-2-bromoethane {ECO:0000269|PubMed:9293022};
CC         KM=0.9 mM for 1,2-dibromopropane {ECO:0000269|PubMed:9293022};
CC         KM=0.05 mM for 1-bromo-2-methylpropane {ECO:0000269|PubMed:9293022};
CC         KM=0.7 mM for 2,3-dichloropropene {ECO:0000269|PubMed:9293022};
CC         KM=0.14 mM for 1-chlorobutane {ECO:0000269|PubMed:10100638};
CC         Note=kcat is 0.98 sec(-1) with 1-chlorobutane as substrate.
CC         {ECO:0000269|PubMed:10100638};
CC       pH dependence:
CC         Optimum pH is 8.2. {ECO:0000269|PubMed:9293022};
CC   -!- PATHWAY: Xenobiotic degradation; gamma-hexachlorocyclohexane
CC       degradation. {ECO:0000305|PubMed:7691794}.
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:9293022}.
CC   -!- SUBCELLULAR LOCATION: Periplasm {ECO:0000269|PubMed:10464214}.
CC   -!- INDUCTION: Constitutively expressed.
CC   -!- MISCELLANEOUS: Is not N-terminally processed during export, so it may
CC       be secreted into the periplasmic space via a hitherto unknown
CC       mechanism. {ECO:0000305|PubMed:10464214}.
CC   -!- SIMILARITY: Belongs to the haloalkane dehalogenase family. Type 2
CC       subfamily. {ECO:0000255|HAMAP-Rule:MF_01231}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D14594; BAA03443.2; -; Genomic_DNA.
DR   EMBL; AP010803; BAI96793.1; -; Genomic_DNA.
DR   PIR; A49896; A49896.
DR   RefSeq; WP_013040256.1; NC_014006.1.
DR   PDB; 1CV2; X-ray; 1.58 A; A=1-296.
DR   PDB; 1D07; X-ray; 2.00 A; A=1-296.
DR   PDB; 1G42; X-ray; 1.80 A; A=1-296.
DR   PDB; 1G4H; X-ray; 1.80 A; A=1-296.
DR   PDB; 1G5F; X-ray; 1.80 A; A=1-296.
DR   PDB; 1IZ7; X-ray; 1.58 A; A=2-296.
DR   PDB; 1IZ8; X-ray; 2.00 A; A=2-296.
DR   PDB; 1K5P; X-ray; 1.80 A; A=2-296.
DR   PDB; 1K63; X-ray; 1.80 A; A=2-296.
DR   PDB; 1K6E; X-ray; 1.85 A; A=2-296.
DR   PDB; 1MJ5; X-ray; 0.95 A; A=1-296.
DR   PDB; 2BFN; X-ray; 1.60 A; A=1-296.
DR   PDB; 4WDQ; X-ray; 1.58 A; A=2-296.
DR   PDB; 4WDR; X-ray; 2.50 A; A/B=4-296.
DR   PDB; 5LKA; X-ray; 1.30 A; A=2-296.
DR   PDB; 6S06; X-ray; 1.15 A; A=1-296.
DR   PDB; 7NFZ; X-ray; 1.55 A; A=1-296.
DR   PDBsum; 1CV2; -.
DR   PDBsum; 1D07; -.
DR   PDBsum; 1G42; -.
DR   PDBsum; 1G4H; -.
DR   PDBsum; 1G5F; -.
DR   PDBsum; 1IZ7; -.
DR   PDBsum; 1IZ8; -.
DR   PDBsum; 1K5P; -.
DR   PDBsum; 1K63; -.
DR   PDBsum; 1K6E; -.
DR   PDBsum; 1MJ5; -.
DR   PDBsum; 2BFN; -.
DR   PDBsum; 4WDQ; -.
DR   PDBsum; 4WDR; -.
DR   PDBsum; 5LKA; -.
DR   PDBsum; 6S06; -.
DR   PDBsum; 7NFZ; -.
DR   AlphaFoldDB; D4Z2G1; -.
DR   SMR; D4Z2G1; -.
DR   STRING; 452662.SJA_C1-19590; -.
DR   ESTHER; sphpi-linb; Haloalkane_dehalogenase-HLD2.
DR   EnsemblBacteria; BAI96793; BAI96793; SJA_C1-19590.
DR   KEGG; sjp:SJA_C1-19590; -.
DR   eggNOG; COG0596; Bacteria.
DR   HOGENOM; CLU_020336_13_3_5; -.
DR   OMA; TLFCQDW; -.
DR   BRENDA; 3.8.1.5; 10293.
DR   UniPathway; UPA00689; -.
DR   Proteomes; UP000007753; Chromosome 1.
DR   GO; GO:0042597; C:periplasmic space; IEA:UniProtKB-SubCell.
DR   GO; GO:0018786; F:haloalkane dehalogenase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0009636; P:response to toxic substance; IEA:UniProtKB-KW.
DR   Gene3D; 3.40.50.1820; -; 1.
DR   HAMAP; MF_01231; Haloalk_dehal_type2; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR000073; AB_hydrolase_1.
DR   InterPro; IPR000639; Epox_hydrolase-like.
DR   InterPro; IPR023594; Haloalkane_dehalogenase_2.
DR   Pfam; PF00561; Abhydrolase_1; 1.
DR   PRINTS; PR00412; EPOXHYDRLASE.
DR   SUPFAM; SSF53474; SSF53474; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Detoxification; Direct protein sequencing; Hydrolase;
KW   Periplasm; Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:10464214,
FT                   ECO:0000269|PubMed:7691794"
FT   CHAIN           2..296
FT                   /note="Haloalkane dehalogenase"
FT                   /id="PRO_0000216778"
FT   DOMAIN          31..155
FT                   /note="AB hydrolase-1"
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        108
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000305|PubMed:10100638,
FT                   ECO:0000305|PubMed:12939138, ECO:0000305|PubMed:14744129"
FT   ACT_SITE        132
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000305|PubMed:10100638,
FT                   ECO:0000305|PubMed:12939138, ECO:0000305|PubMed:14744129"
FT   ACT_SITE        272
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000305|PubMed:10100638,
FT                   ECO:0000305|PubMed:12939138, ECO:0000305|PubMed:14744129"
FT   BINDING         38
FT                   /ligand="chloride"
FT                   /ligand_id="ChEBI:CHEBI:17996"
FT                   /evidence="ECO:0000269|PubMed:14744129"
FT   BINDING         109
FT                   /ligand="chloride"
FT                   /ligand_id="ChEBI:CHEBI:17996"
FT                   /evidence="ECO:0000269|PubMed:14744129,
FT                   ECO:0000269|PubMed:17259360, ECO:0007744|PDB:1MJ5,
FT                   ECO:0007744|PDB:2BFN"
FT   MUTAGEN         38
FT                   /note="N->D,E,F,Q: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:12450392"
FT   MUTAGEN         108
FT                   /note="D->A: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:10100638"
FT   MUTAGEN         108
FT                   /note="D->N: 58% of wild-type activity."
FT                   /evidence="ECO:0000269|PubMed:10100638"
FT   MUTAGEN         109
FT                   /note="W->L: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:12450392"
FT   MUTAGEN         132
FT                   /note="E->Q: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:10100638"
FT   MUTAGEN         151
FT                   /note="F->L,W,Y: Increase in activity."
FT                   /evidence="ECO:0000269|PubMed:12450392"
FT   MUTAGEN         169
FT                   /note="F->L: 31% of wild-type activity."
FT                   /evidence="ECO:0000269|PubMed:12450392"
FT   MUTAGEN         244
FT                   /note="E->Q: 38% of wild-type activity."
FT                   /evidence="ECO:0000269|PubMed:10100638"
FT   MUTAGEN         272
FT                   /note="H->A: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:10100638"
FT   STRAND          12..16
FT                   /evidence="ECO:0007829|PDB:1MJ5"
FT   STRAND          19..27
FT                   /evidence="ECO:0007829|PDB:1MJ5"
FT   STRAND          29..35
FT                   /evidence="ECO:0007829|PDB:1MJ5"
FT   HELIX           42..45
FT                   /evidence="ECO:0007829|PDB:1MJ5"
FT   TURN            46..48
FT                   /evidence="ECO:0007829|PDB:1MJ5"
FT   HELIX           49..52
FT                   /evidence="ECO:0007829|PDB:1MJ5"
FT   STRAND          55..61
FT                   /evidence="ECO:0007829|PDB:1MJ5"
FT   TURN            77..80
FT                   /evidence="ECO:0007829|PDB:6S06"
FT   HELIX           82..95
FT                   /evidence="ECO:0007829|PDB:1MJ5"
FT   STRAND          102..107
FT                   /evidence="ECO:0007829|PDB:1MJ5"
FT   HELIX           108..120
FT                   /evidence="ECO:0007829|PDB:1MJ5"
FT   HELIX           121..124
FT                   /evidence="ECO:0007829|PDB:1MJ5"
FT   STRAND          125..132
FT                   /evidence="ECO:0007829|PDB:1MJ5"
FT   HELIX           140..142
FT                   /evidence="ECO:0007829|PDB:1MJ5"
FT   HELIX           145..147
FT                   /evidence="ECO:0007829|PDB:1MJ5"
FT   HELIX           148..155
FT                   /evidence="ECO:0007829|PDB:1MJ5"
FT   HELIX           159..163
FT                   /evidence="ECO:0007829|PDB:1MJ5"
FT   TURN            164..166
FT                   /evidence="ECO:0007829|PDB:1MJ5"
FT   HELIX           168..171
FT                   /evidence="ECO:0007829|PDB:1MJ5"
FT   HELIX           173..176
FT                   /evidence="ECO:0007829|PDB:1MJ5"
FT   STRAND          178..180
FT                   /evidence="ECO:0007829|PDB:1MJ5"
FT   HELIX           184..191
FT                   /evidence="ECO:0007829|PDB:1MJ5"
FT   HELIX           192..194
FT                   /evidence="ECO:0007829|PDB:1MJ5"
FT   STRAND          196..198
FT                   /evidence="ECO:0007829|PDB:1MJ5"
FT   HELIX           199..201
FT                   /evidence="ECO:0007829|PDB:1MJ5"
FT   HELIX           202..206
FT                   /evidence="ECO:0007829|PDB:1MJ5"
FT   HELIX           208..210
FT                   /evidence="ECO:0007829|PDB:1MJ5"
FT   HELIX           218..231
FT                   /evidence="ECO:0007829|PDB:1MJ5"
FT   STRAND          238..245
FT                   /evidence="ECO:0007829|PDB:1MJ5"
FT   STRAND          247..250
FT                   /evidence="ECO:0007829|PDB:1MJ5"
FT   HELIX           251..257
FT                   /evidence="ECO:0007829|PDB:1MJ5"
FT   STRAND          261..272
FT                   /evidence="ECO:0007829|PDB:1MJ5"
FT   HELIX           274..276
FT                   /evidence="ECO:0007829|PDB:1MJ5"
FT   HELIX           279..293
FT                   /evidence="ECO:0007829|PDB:1MJ5"
SQ   SEQUENCE   296 AA;  33108 MW;  6EEE011B157DBAE1 CRC64;
     MSLGAKPFGE KKFIEIKGRR MAYIDEGTGD PILFQHGNPT SSYLWRNIMP HCAGLGRLIA
     CDLIGMGDSD KLDPSGPERY AYAEHRDYLD ALWEALDLGD RVVLVVHDWG SALGFDWARR
     HRERVQGIAY MEAIAMPIEW ADFPEQDRDL FQAFRSQAGE ELVLQDNVFV EQVLPGLILR
     PLSEAEMAAY REPFLAAGEA RRPTLSWPRQ IPIAGTPADV VAIARDYAGW LSESPIPKLF
     INAEPGALTT GRMRDFCRTW PNQTEITVAG AHFIQEDSPD EIGAAIAAFV RRLRPA
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024